Congenital mixed malignant germ cell tumor involving cerebrum and orbit
-
J.-C. Lee
Abstract
Congenital intracranial tumors are rare and only account for 0.5 to 1.5% of all pediatric brain tumors. Teratoma is the most frequently encountered intracranial tumor at birth. Cephalomegaly and hydrocephalus are the usual clinical presentations. Advances in imaging techniques have improved diagnostic accuracy in congenital brain tumors. But the prognosis of a massive intracranial teratoma is always dismal. We report a congenital mixed malignant germ cell tumor in a male fetus at 27 weeks of gestation, with massive involvement of cerebrum and orbit. According to histological and immunohistochemical studies, the tumor was made up of predominantly immature teratoma combined with a yolk sac tumor. To our knowledge, such a combination has not been well documented in the literature.
Copyright © 2003 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- Telemedicine for antenatal surveillance of high-risk pregnancies with ambulatory and home fetal heart rate monitoring – an update
- The HELLP-syndrome; maternal-fetal outcome and follow up of infants
- Effect of maternal age on blood loss during parturition: a retrospective multivariate analysis of 10,053 cases
- Prenatal medicine related to stress and depressive reactions of pregnant women and their partners
- Accuracy of sonographic estimation of fetal weight before induction of labor in diabetic pregnancies and pregnancies with suspected fetal macrosomia
- Validity of short term variation (STV) in detection of fetal acidemia
- Amikacin alters auditory brainstem conduction time in newborns
- Triplets and quadruplets in Switzerland: comparison with singletons, and evolution over the last decade
- Maternal smoking during pregnancy and appetite control in offspring
- Sequential use of thrombolytic agents for thrombosed mitral valve prosthesis during pregnancy
- Congenital mixed malignant germ cell tumor involving cerebrum and orbit
- Jejunal atresia related to the use of toluidine blue in genetic amniocentesis in twins
- Congress Calendar
Articles in the same Issue
- Telemedicine for antenatal surveillance of high-risk pregnancies with ambulatory and home fetal heart rate monitoring – an update
- The HELLP-syndrome; maternal-fetal outcome and follow up of infants
- Effect of maternal age on blood loss during parturition: a retrospective multivariate analysis of 10,053 cases
- Prenatal medicine related to stress and depressive reactions of pregnant women and their partners
- Accuracy of sonographic estimation of fetal weight before induction of labor in diabetic pregnancies and pregnancies with suspected fetal macrosomia
- Validity of short term variation (STV) in detection of fetal acidemia
- Amikacin alters auditory brainstem conduction time in newborns
- Triplets and quadruplets in Switzerland: comparison with singletons, and evolution over the last decade
- Maternal smoking during pregnancy and appetite control in offspring
- Sequential use of thrombolytic agents for thrombosed mitral valve prosthesis during pregnancy
- Congenital mixed malignant germ cell tumor involving cerebrum and orbit
- Jejunal atresia related to the use of toluidine blue in genetic amniocentesis in twins
- Congress Calendar
